Table 3 KPS and analgesic scores pre- and post-PRRT
From: Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
KPS | Baseline | Post-therapy | P value |
|---|---|---|---|
KPS (in PR patients) | 62.5 ± 17 | 80 ± 8 | 0.068 |
KPS (in SD patients) | 66.9 ± 10.4 | 78.5 ± 9.4 | 0.002 |
KPS (in PD patients) | 65 ± 8.3 | 18 ± 29.9 | 0.008 |
Analgesic score | 4.3 ± 1.2 | 3.1 ± 1.1 | 0.000 |